U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H36O9
Molecular Weight 540.6014
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIMBIN

SMILES

COC(=O)C[C@H]1[C@@]2(C)[C@H](O[C@@H]3C[C@@H](C4=COC=C4)C(C)=C23)[C@H](OC(C)=O)[C@H]5[C@@](C)(C=CC(=O)[C@]15C)C(=O)OC

InChI

InChIKey=NHOIBRJOQAYBJT-IMGVWCFESA-N
InChI=1S/C30H36O9/c1-15-18(17-9-11-37-14-17)12-19-23(15)30(5)20(13-22(33)35-6)29(4)21(32)8-10-28(3,27(34)36-7)25(29)24(26(30)39-19)38-16(2)31/h8-11,14,18-20,24-26H,12-13H2,1-7H3/t18-,19-,20-,24-,25+,26-,28-,29+,30-/m1/s1

HIDE SMILES / InChI

Description

Nimbin is the active compound from the neem leaf extract which is now being tested in silico as a potential remedy against tuberculosis and dengue virus. Recent studies have shown that the drug interacts with NS2B-NS3 protease from dengue virus and fatty acid synthase of Mycobacterium tuberculosis. Nimbin can also be used as a pesticide.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
NlE-115, 143B. TK- and Sf9 cells were exposed for 24 hr to serial dilutions of Nimbin up to 200 uM to test the drug cytotoxicity.